ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
56 hedge funds and large institutions have $12.5M invested in Zynerba Pharmaceuticals, Inc in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less capital invested
Capital invested by funds: $24.9M → $12.5M (-$12.4M)
Holders
56
Holding in Top 10
–
Calls
$109K
Puts
$40K
Top Buyers
| 1 | +$466K | |
| 2 | +$346K | |
| 3 | +$62.3K | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$43K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$35K |
Top Sellers
| 1 | -$1.4M | |
| 2 | -$271K | |
| 3 | -$221K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$168K |
| 5 |
Jane Street
New York
|
-$130K |